FRANK P. PALOUCEK, Pharm.D. FASHP, FAACT, DPLA, DABAT
FRANK P. PALOUCEK, Pharm.D. FASHP, FAACT, DPLA, DABAT5129 Grand AvenueWestern Springs Illinois 60558708-784-0803 (H)708-323-6727 (M)paloucek@uic.eduAdministrative OfficeUniversity of Illinois at ChicagoCollege of PharmacyDepartment of Pharmacy Practice, (M/C 886)833 South Wood StreetChicago, Illinois 60612312-996-5328 (P)312-996-0379 (F)EDUCATION/POST-GRADUATE TRAININGResearch Fellowship in Clinical PharmacokineticsUIC College of PharmacyJuly 1985 - July 1986Clinical Pharmacy ResidencyUniversity of Illinois HospitalJuly 1984 - July 1985Doctor of Pharmacy,Philadelphia College of Pharmacy & SciencesSeptember 1982 - May 1984Bachelor of Science in PharmacyUniversity of Illinois at ChicagoJune 1978 - July 1981LICENSUREState of Illinois # 051-033829BOARD CERTIFICATIONAmerican Board of Applied ToxicologyPoison Prevention EducatorSeptember 1991- presentMarch 2006 - presentACADEMIC APPOINTMENTSClinical ProfessorDepartment of Pharmacy PracticeUIC College of Pharmacy – Voting MemberJuly 2014 - presentAffiliate Associate ProfessorDepartment of PharmacyUniversity of MaltaApril 2015 - presentClinical Associate ProfessorJuly 1994- July 2014
Emergency MedicineUIC College of Medicine- Nonvoting MemberClinical Associate ProfessorDepartment of Pharmacy PracticeUIC College of Pharmacy - Voting MemberJuly 1994 – 2014Clinical Assistant ProfessorEmergency MedicineUIC College of Medicine- Nonvoting MemberJuly 1992 – 2010Clinical Assistant ProfessorDepartment of Pharmacy PracticeUIC College of PharmacyJuly 1986 - June 1994Clinical InstructorDepartment of Pharmacy PracticeUIC College of PharmacyJuly 1984- June 1986PROFESSIONAL EXPERIENCEDirector, PGY1 Pharmacy Residency ProgramUniversity of Illinois College of PharmacyJuly 1999 – June 2019Attending ToxicologistToxikon ConsortiumApril 1990 - presentDirector, PGY2 Emergency Medicine ResidencyUniversity of Illinois HospitalJuly 1991-1999Director, Fellowship Clinical ToxicologyJuly 1991-1999Clinical Pharmacist- Emergency MedicineEmergency Medicine/Clinical ToxicologyUIC College of Pharmacy - Voting MemberJuly 1988 - June 1994Clinical Assistant ProfessorInternal Medicine/NephrologyUIC College of PharmacyJuly 1986 - June 1988Clinical Pharmacist in Drug InformationHospital of University of PennsylvaniaMay 1984 - July 1984Staff Pharmacist (Part-Time)Thomas Jefferson University HospitalSeptember 1982 - May 1984Staff Pharmacist in Drug InformationUniversity of Illinois HospitalJuly 1981 - August 1982TEACHING EXPERIENCE (active roles and classes)
POST-GRADUATE TRAININGUIC PGY1 Pharmacy Residency PreceptorAugust 1986 - presentUIC PGY2 Critical Care Residency PreceptorUIC PGY2 Emergency Medicine PreceptorJuly 2000 - presentJuly 1989 - presentPOST-GRADUATE DIDACTICLecturer Residency Teaching Certificate ProgramJuly 2002 - presentPOST-GRADUATE EXPERIENTIALUNDERGRADUATE DIDACTICCourse CoordinatorPMPR 359Special Topics - Postgraduate Training (2001-present)PMPR 345Clinical Toxicology (2000 – present)Lecturer – College CurriculumPHAR 357BPS 542PDAT 407PDAT 405PMPR 440PMPR 318Experiential V (5 minute case presentations)Pharmacodynamics of Drug Abuse (Drug Abuse and the Internet)Principles Drug Actions and Therapeutics (Acid:Base Disorders)Principles Drug Actions and Therapeutics (General Poison Management)Clinical Pharmacokinetics (Non Steady-state Pharmacokinetics)Foundations in rural family medicine (Rural Toxicology)LecturerHon 201PMAD 381BIOS 196Honors College Seminar SeriesProfessional Development SeminarBiology Colloquium – Poison and poisoningsUNDERGRADUATE EXPERIENTIALUndergraduate Student PreceptorPMPR 387Advanced Medicine ClerkshipPUBLICATIONSBooksLeikin JB, Paloucek FP. Handbook of Poisoning/Toxicology, 4th edition. CRC Press,Taylor & Francis Group, Boca Raton, Florida, 2008.Leikin JB, Paloucek FP. Handbook of Poisoning/Toxicology 2001-2002, 3rd edition.Lexicomp, Hudson Ohio, 2001.
Leikin JB, Paloucek FP. Poisoning & Toxicology Compendium. Lexicomp, Hudson Ohio,1998.Leikin JB, Paloucek FP. Handbook of Poisoning/Toxicology 1996-1997, 2nd edition.Lexicomp, Hudson Ohio, 1995.Leikin JB, Paloucek FP. Handbook of Poisoning/Toxicology. Lexicomp, Hudson Ohio,1995.Book ChaptersPaloucek FP. Pharmacokinetics and Toxicokinetics. The Clinical Toxicology Laboratory:Contemporary Practice of Poisoning Evaluation, 2nd Ed. Shaw LM, Kwong TC, RosanoTG, et al, eds. AACC, Washington DC, 2012.Clinical Biomarkers Used to Diagnose and Treat Acute Poisoning in Humans. Report onthe ICCVAM-NICEATM/ECVAM/JaCVAM Scientific Workshop on Acute ChemicalSafety Testing: Advancing In Vitro Approaches and Humane Endpoints for SystemicToxicity Evaluations.Paloucek FP, Shannon MS. Theophylline Toxicology In: Pediatric Toxicology. EricksonT, Aks S, Ling L, Baum C, Ahrens WR, eds. McGraw-Hill, New York 2004.Paloucek FP, Baum C. Overview of Pediatric Prescription Drug Poisoning. ” In: PediatricToxicology. Erickson T, Aks S, Ling L, Baum C, Ahrens WR, eds. McGraw-Hill, NewYork 2004.Paloucek FP. Clinical Pediatric Toxicokinetics. In: Pediatric Toxicology. Erickson T,Aks S, Ling L, Baum C, Ahrens WR, eds. McGraw-Hill, New York 2004.Paloucek FP. Theophylline Poisoning. In: Rosen’s 5-minute Emergency MedicineConsult, 2nd edition. Lippincott, Williams & Wilkin. Philadelphia, PA 2003.Paloucek FP. Therapeutic drug monitoring. In: Irwin and Rippe’s Intensive CareMedicine, 5th edition. Lippincott, Williams & Wilkins, Philadelphia, PA, 2003Paloucek FP. Theophylline toxicity. In: Pediatric Emergency Medicine: A ComprehensiveStudy Guide, 2nd edition. Strange GR, Ahrens WR, Lelyveld S, Schafermeyer RW, eds.McGraw-Hill, New York, 2002.Paloucek FP. Pharmacokinetics. The Clinical Toxicology Laboratory: ContemporaryPractice of Poisoning Evaluation. Shaw LM, Kwong TC, Rosano TG, et al, eds. AACC,Washington DC, 2001.Watson WA, Paloucek FP. Managing Acute Drug Toxicity. In: Applied Therapeutics: TheClinical Use of Drugs Seventh ed. Young LY, Koda Kimble MA, ed. Lippincott, Williams& Wilkins, Baltimore, 2001.
Choi H, Paloucek FP. Lithium Toxicity. In: Toxicology Secrets. Ling L, Clark R, EricksonT, Trestrial J, ed. Lamsback, Hanley and Belfus, Inc. Medical Publishers, Philadelphia.2001.Paloucek FP, Rynn KO. Nonsteroidal anti-inflammatory agents clinical toxicology. In:Clinical Toxicology. Ford M, Ling L, Erickson TE, et al, eds. W.B. Saunders,Philadelphia, 2001.Paloucek FP. Clinical Pharmacokinetics and Toxicokinetics. In: Drug InformationHandbook for the Criminal Justice Professional. Burns M, Page TE, and Leikin JB, eds.,Lexicomp, Hudson, Ohio, 1998.Paloucek FP. Pharmacokinetics. Contemporary Practice in Clinical Toxicology FirstEdition. Shaw LM, Kwong TC, Orsulak PJ, et al, eds. AACC, Washington DC, 1998.Paloucek FP. Theophylline toxicity. In: Pediatric Emergency Medicine. Strange G,Schafermeyer R, Ahrens W, Lelyveld S, eds. McGraw-Hill, New York, 1995.Paloucek FP. Hypertensive urgencies and emergencies, in Module I - Cardiovascular.PSAP II. American College of Clinical Pharmacy, Kansas City, Missouri, 1995.Electronic media publicationsStockpiling in General Emergency Preparedness. Illinois Emergency Preparedness andResponse Education Network. http://www.epr-education.net, September 2005.Paloucek FP. Pharmacokinetics. Laboratory Evaluation of the Poisoned Patient – ATeaching Slide Set, First Edition. Shaw LM, Kwong TC, Orsulak PJ, et al eds. AACC,Washington DC, 2003.Peer-reviewed publicationsPaloucek FP, Petzel R. A more simplified and practical loading dose formula for antidotaloral ethanol for toxic acholos. Am J Emerg Med 2019 Aug 24. pii: S07356757(19)30550-9. doi: 10.1016/j.ajem.2019.158413. [Epub ahead of print].Cook AM, Martin C, Rowe AS, Davis SL, Paloucek FP. Problems with the currentapproach to residency research. Am J Health Syst Pharm 2016;73:1918-22.Mohammadi F, Maclasco A, Paloucek FP. Inappropriate utilization of the Sheiner-Tozerequation to determine phenytoin toxicity. Am J Emerg Med 2015;33:467-8.Paloucek FP. A better letter of intent for pharmacy residency applications. Am J HealthSyst Pharm 2011:68;2218.Aazami R, Clements EA, Cobaugh DJ, Paloucek FP (as members of the ASHP Sectionof Clinical Specialists and Scientists Section Advisory Group on Emergency Care).ASHP Statement on Pharmacy Services to the Emergency Department. Am J HealthSyst Pharm 2008; 65:2380-3.
Mancuso C, Paloucek FP. Understanding and preparing for pharmacy practice residencyinterviews. Am J Health-Syst Pharm 2004;61:1686-9.Bryant S, Bellamy L, Paloucek FP , Wahl M,. Acute acetaminophen poisoning inchildren: kids aren’t just little adults. J Emerg Med 2003:24:472-3.Pai MP, Paloucek FP. The origin of the “ideal” body weight equation. Ann Pharmacother2000;34:1066-9.Paloucek FP. Antidotal flumazenil use - the protamine of the 90’s. Crit Care Med1999;27:10-11.Gordon RA, Roberts G, Amin Z, Williams RH, Paloucek FP. Aggressive approach in thetreatment of acute lead encephalopathy with an extraordinarily high concentration oflead. Arch Pediatr Adolescent Med 1998;152:1100-1104.Chyka PA, Hornfeldt CS, Howland MA, Kearney TE, Manoguerra AS, Paloucek FP,Scharman EJ, Trestrail JH 3rd, Watson WA. Prophylaxis of seizures after theophyllineoverdose. Pharmacotherapy 1997;17:1044-5Rynn KO, Graf S, Paloucek FP. Selective prescribing in suicidal patients: a little thoughtcan decrease the risk of future morbidity and mortality. Ann Pharmacother 1997;31:9245.Bizovi KE, Aks SE, Paloucek FP, et al. Late increase in acetaminophen concentrationafter overdose of Tylenol extended relief. Ann Emerg Med 1996;28:549-51.Paloucek FP. Editorial: Fosphenytoin safety and economics. Am J Health-Syst Pharm1996;53:2702.Gorman SE, Dela Cruz F, Paloucek FP. Ketoconazole and zidovudine overdose. Am JEmerg Med 1995;13:115-6.Gentry CA, Paloucek FP, Rodvold KA. Prediction of acetaminophen concentrations inoverdose patients using a Bayesian pharmacokinetic model. J Toxicol Clin Toxicol 1994;32:17-30.Leikin JB, Linoweicki KA, Soglin DF, Paloucek FP. Hypokalemia after pediatric albuteroloverdose: a case series. Am J Emerg Med 1994; 12:64-6.Paloucek FP. Lead poisoning. Am Pharm 1993; NS33:81-88; quiz 88-90.Linoweicki K. Paloucek FP, Donnelly A, Leikin JB. Reversal of ethanol-inducedrespiratory depression by flumazenil. Vet Human Toxicol 1992;34:417-19.Kisch GL, Paloucek FP. Metered-dose inhalers and nebulizers in the acute setting: areview of clinical trials. Ann Pharmacother 1992; 26:92-5.Lewis R, Paloucek FP. Assessment and treatment of acetaminophen overdose. ClinPharm 1991;10:765-74.
Tyree D, Paloucek FP. Personal shampoos and safety considerations. Am J HospPharm 1991; 48:937-8.Just V, Paloucek FP, Schrader B, Bauman J. Evaluation of drug therapy for treatment ofhypertensive urgencies in the emergency department. Am J Emerg Med 1991; 9:107111.Lebby T, Paloucek FP, DelaCruz F, Leikin JB. Blood pressure decrease prior to initiatingpharmacologic therapy in non-emergent hypertension. Am J Emerg Med 1990;8:27-29.Paloucek FP, Bauman J. Acute Theophylline toxicity. Hosp Therapy 1989; 14:45-53.Fischer JH, Barr AN, Paloucek FP, Dorociak JV, Spunt AL. Effect of food on the serumconcentration profile of enteric-coated valproic acid. Neurol 1988; 38:1319-1322.Paloucek FP, Rodvold KA. Evaluation of theophylline overdoses and toxicities. AnnEmerg Med 1988; 17:135-44.Rodvold KA, Paloucek FP, Jung DT, Gallastegui J. Interaction of steady-stateprocainamide with H2-receptor antagonists cimetidine and ranitidine. Ther Drug Monitor1987; 9: 378-83.Aronson IK, Rumsfield JA, West DP, Alexander J, Fischer JH, Paloucek FP.Evaluation of topical metronidazole gel for the treatment of acne rosacea. DrugIntell Clin Pharm 1987; 21: 346-51.Rodvold KA, Paloucek FP, Zell M. Accuracy of 11 methods for predicting theophyllinedose. Clin Pharm 1986; 5: 403-8.Stringer KA, Paloucek FP. Methylprednisolone in acute asthma N Engl J Med1986;314:1704-5.Lee M. Paloucek FP, Sharifi R. Additional sources of immunobiologicals. West J Med1983; 138: 424-5.Non-peer reviewed publicationsGraf S, Paloucek FP, Rynn KO. Drug-induced methemoglobinemia. KeepPosted: IllinoisPharmacists Association Newsletter 1997;22:8-11.Paloucek FP. Reactions to fosphenytoin editorial and review article. Am J Health-SystPharm 1997;54:449.Leikin JB, Shicker L, Hryhorczuk D, et al. Exploring the facts on the odorless, colorlesskiller. Chicago Med 1995;98:12-5.Paloucek FP. Book Review: Principles of Clinical Toxicology. Ann Pharmacother1995;29:541-2.Pharmaceutical care and activated charcoal. The University of Illinois at Chicago Collegeof Pharmacy Continuing Education, Chicago, Il 1994
Paloucek FP. A Pharmacist's guide to lead poisoning prevention and treatment. OneMinute Counselor, APhA November 1993.Paloucek FP. Theophylline toxicokinetics. J Pharm Pract 1993;6:57-62.Paloucek FP, Linoweicki KA. Pharmaceutical care in the management of the poisonedpatient. Ill Pharmacist 1992;54:11-2,21,24.Paloucek FP, Rodvold KA. Theophylline therapy: a reply. Ann Emerg Med 1989;18:426.Geraci M, Keuhl P, Paloucek F. Development and validation of a programmedevaluation for external Pharm.D. students. Contant panelist: Clinical Therapeutics TestBank. Wrote, edited and approved questions for a 302 question test bank.Stringer KA, Paloucek FP. Methylprednisolone in acute asthma. N Engl J Med 1986;314:1704-5.Paloucek F, Lee M. Diluting insulin. Drug Dex, 1982Paloucek FP. Additional contributor, drug information division. In: 1983 USPDI. TheUnited States Pharmacopeia Convention, Inc., Rockville, Maryland, 1982.SCIENTIFIC EXHIBITS AND ABSTRACTSLuman TT, Caldero LB, Alsultan RF, Paloucek FP. Breathe easy! Don’t drown in theflash flood of case reports- A review of naloxone and pulmonary edema cases. 2017Annual ASHP Midyear Meeting, Orlando, FL, December 2017.Paloucek FP, Patel C, Khosla S, Popovioch N. “Does personality type influence theselection of Doctor of Pharmacy candidates for a PGY1 residency”Guthrie AM, Petzel-Gimbar RM, Paloucek FP. Palatability of effervescent vs standardoral n-acetylcyteine: Is it worth all the fizz. 2017 North American Congress ClinicalToxicology, Vancouver, BC October 2017.Nguyen T, Petzel RM, Paloucek FP. Descriptive analysis of patients receiving digoxinimmune Fab therapy: Demographics, concentrations recommendations. 2013 AnnualNACCT Scientific Meeting, Atlanta, GA, September 2013.Nguyen T, Petzel R, Paloucek FP. Characterizing Methanol Elimination in ToxicOverdose. 2012 Annual NACCT Scientific Meeting, Las Vegas, NV, September 2012.Paloucek FP, Bryant SM. Does Measured Serum Osmolarity Alone Predict EthyleneGlycol Toxicity. 2010 Annual NACCT Scientific Meeting, Denver CO October 2010.Does Measured Serum Osmolarity Alone Predict Methanol Toxicity. 2010 NACCTAnnual Scientific Meeting, Denver, CO, October 2010.
Grider L, Donnelly AJ, Paloucek FP. Integration of management theory into a pharmacypractice residency program. 2005 ASHP Annual Midyear Meeting Clinical Meeting, LasVegas, Nevada, December 2005.Rhee JW, Diaz A, Paloucek FP, Erickson TB. Unknown Radio-opaque MaterialObscuring the Diagnosis of Appendicitis. 2005 Annual NACCT Scientific Meeting,Orlando, FL, September 2005.Peverly SL, Paloucek FP. A Bridge to Quality: A Multidisciplinary BioterrorismCurriculum. Poster Session, 2005 AACP Annual Meeting and Seminars, Cincinnati, OHJuly, 2005.Mancuso CE, Moody ML, Paloucek FP, Eyrich HM. Evaluation of Drug InformationResources in Emergency Departments. 2004 ASHP Annual Midyear Clinical Meeting,Orlando, FL, December 2004.Paloucek FP. The Story of Oleander Poisoning. Platform Presentation, ToxicologyHistorical Society, 2004 NACCT Annual Scientific Meeting, Seattle, WA, September2004.Paloucek FP. Review of pediatric mortality reported by TESS from 1997-2001. 2004NACCT Annual Scientific Meeting, Seattle, WA, September 2004.Mancuso CE, Moody ML, Paloucek FP, Eyrich HM. Evaluation of Drug InformationResources in Emergency Departments. 19th Annual Great Lakes Pharmacy ResidentConference, West Lafayette, IN, April 2004.Jeddy AS, Paloucek FP. An Assessment of Consistency in Faculty Recommendations toStudents Applying to Pharmacy Practice Residencies. 19th Annual Great LakesPharmacy Resident Conference, West Lafayette, IN, April 2004.Paloucek FP, Aks S, Erickson TB. Famous Chicago Poisonings. Platform PresentationToxicology Historical Society, 2003 NACCT Annual Scientific Meeting, Chicago, ILSeptember 2003.Chan LT, Costianis R, Paloucek FP, Baum C. Determining the Interrelationshipsbetween Ethanol Kinetics and P-glycoprotein Activity in Humans. 17th Annual GreatLakes Pharmacy Practice Residency Conference, West Lafayette, IN May 2003.Murphy J, Paloucek FP. Analysis of the Pharmacy Resident Seminar EvaluationProcess. 17th Annual Great Lakes Pharmacy Practice Residency Conference, WestLafayette, IN May 2003.Mancuso C, Paloucek FP. Interview Selection Processes and Interview SelectionCriteria for Pharmacy Practice Residents. 17th Annual Great Lakes Pharmacy PracticeResidency Conference, West Lafayette, IN, May 2003.Bryant S, Paloucek FP. IRB Submission Practices when Utilizing Poison Center Data.2002 NACCT Annual Scientific Meeting, Palm Springs, CA, September 2002.
Doherty C, Koronkowski M, Paloucek FP, Mobley-Smith M. Health-related communityoutreach assessment among ASHP accredited pharmacy practice residency programs.18th Annual Great Lakes Pharmacy Residency Conference, West Lafayette, IN, April2002.Grider L, Paloucek FP, Larson C. Administrative Rotation for Pharmacy PracticeResidents. ASHP Midyear Annual Meeting 2001, New Orleans, LA, December 2001.Mentler PA, Paloucek FP. Treatment Recommendations Specified by Various SpecialtyResources for the Treatment of Hydrofluoric Acid Exposures to the Hand. 17th AnnualGreat Lakes Residency Conference, Indianapolis, IN, April 2001.Khorana KS, Paloucek FR. Survey of Selection Criteria for Pharmacy PracticeResidents. 17th Annual Great Lakes Residency Conference, Indianapolis, IN, April 2001.Einhorn AE, Paloucek FP. Survey of Critical Care Pharmacy Programs for Training inEmergency Medicine and Toxicology. 16th Annual Great Lakes Residency Conference,Madison, WI, April 2001.Lau R, Paloucek FP. Perception and Value of a Clinical Pharmacy Resident/fellowbased On-call Program. 15th Annual Great Lakes Residency Conference, Columbus,OH, October 2000.Stigler JH, Paloucek FP. Clinical Toxicology Training of Pharmacy Students in theUnited States. 15th Annual Great Lakes Residency Conference, Columbus, OH, October2000.Webster K, Burda T, Sigg T, O’Neill L, Paloucek FP, Kaputska C. Antidote Preparednessof Illinois Hospitals. ACCP Annual Meeting, Kansas City, MO, October 1999.Viner K, Clifton JC, Hryhorczuk D, Paloucek FP, et al. Status Epilepticus FollowingTiagabine Overdose. 1999 NACCT Annual Meeting La Jolla, CA, September 1999.Paloucek FP, Patel H, Navada S. Toxic Bromethalin Exposure in a Pediatric Patient.Third Annual Student and Resident Research Poster Forum. University of Chicago atIllinois, Chicago, IL, April 1997.Miner P, Vanvaley K, Paloucek FP. A Case of Sodium Bromate Poisoning. EighteenthAnnual Undergraduate Research Seminar, Charleston, WV, October 1996.Hoffmeister A, Paloucek FP, Rynn KO. Value of Screening for Acetaminophen inSuspected Overdose Patients. Second Annual Student and Resident Research PosterForum, UIC COP, Chicago, IL, March 1996.Rynn KO, Jahns BE, Paloucek FP. Acute Myocardial Infarction Associated withBenzocaine-induced Methemoglobinemia. 1995 North American Congress of ClinicalToxicology, Rochester, NY, September 1995.Jahns BE, Rynn KO, Paloucek FP. Mannitol for Severe Ciguatera Intoxication. 1995North American Congress of Clinical Toxicology, Rochester, NY, September1995
Paloucek FP, Jahns BE, Woods K, Leikin JB. Neonatal Theophylline Toxicity: Do WeTrust the History Too Much? 1995 North American Congress of Clinical Toxicology,Rochester, NY, September 1995.Tillman DJ, Poddig BE, Watanabe MD, Paloucek FP. Sodium polysterene sulfonateversus polyethylene glycol solution in th
FRANK P. PALOUCEK, Pharm.D. FASHP, FAACT, DPLA, DABAT 5129 Grand Avenue Western Springs Illinois 60558 708-784-0803 (H) 708-323-6727 (M) paloucek@uic.edu Administrative Office University of Illinois at Chicago College of Pharmacy Department of Pharmacy Practice, (M/C 886) 833 S
May 25, 2020 · PHARM 539 Princ Pharm Management 3 PHARM 543b Pharm Law/Ethics 3 PHARM 563 Applied Ptherapeutics I 2 PHARM 537 Chem Depend Conc 2 PHARM 593 Pharmacy Practice V 3 PHARM 594 Pharmacy Practice VI 2 PHARM 592 Pharm Practice IV 3 PharmP 514 IPPE 1 PharmP 531 IPPE* 1 PharmP 513 IPPE 1 PharmP 52
ENG 300 (Functional English) PHARM 310 PHARM 311 PHARM 312 PHARM 313 PHARM 314 English-A (Communication & Writing Pharmaceutics-IA (Physical Pharmacy) Pharmaceutical Chemistry-IA (Organic) Pharmaceutical Chemistry-IIA (Biochemistry) Physiology-A Anatomy & Histology 2 3 1 3 1 3 1 3 1 3 1 ENG 301 PHARM 315
M.Pharm. Integrated first degree of BITS in Pharmacy or its equivalent GPAT M.Pharm. (Specialization in Pharmaceutical Chemistry) M.Pharm. (Specialization in Pharmaceutics) M.Pharm. (Specialization in Pharmacology) Candidates applying to any of the four M.Pharm
KOREA PHARM 2014 10(Tue.) 13(Fri.) June 2014 KINTEX, KOREA KOREA PHARM, Korea's representing Pharmaceutical Exhibition On behalf of Organizer, we cordially invite you to KOREA PHARM 2014 to be held on June 10 13,
BEFORE THERE WAS PHARM -2-PHARM, THERE WAS THE MINNESOTA EXPERIENCE *“Beginning in 1999, Fairview Health Services of Minneapolis/St. Paul implemented the ‘Collaborative Practice of Pharmaceutical Care’ at 6 of 15 primary care clinics, where pharmacists now p
Post-Pharm.D. Master of Science in Pharmacy Committee 2015-2017 David Huggar, Pharm.D., MS (Member) (now: HEOR Field Execu-tive at Celgene) 2014–2016 Isaac Pan, Pharm.D., MS (now: Clinical Pharmacy Specialist, Mental Health at VA Texas Valley Coastal Bend Healt
Syllabus of Sixth Semester B. Pharm. 069 11. Syllabus of Seventh Semester B. Pharm. 081 12. Syllabus of Eight Semester B. Pharm. 091 B Ordianance and Rules (M. Pharm.) 101 1. Ordinance and Rules 102 2. Structure of Syllabus 107 C. Syllabus (Pharmaceutics) 115 D. Syllabus (
ASME A17.1, Safety Code for Elevators and Escalators, International Building Code, and other non-governmental safety standards identify minimum design requirements for elevators and for building systems that interface with the elevator controls. The performance language